share_log

AbbVie | 144: Notice of proposed sale of securities pursuant to Rule 144

AbbVie | 144: Notice of proposed sale of securities pursuant to Rule 144

艾伯维公司 | 144:拟议出售证券
美股sec公告 ·  03/18 17:07
Moomoo AI 已提取核心信息
AbbVie Inc. officer Stewart Jeffrey Ryan is set to sell 58,949 common shares of the company on March 18, 2024, with an aggregate market value of approximately $10,539,878. The shares to be sold were acquired through stock option exercises and performance shares, both as compensation from the issuer. On March 18, 2024, Ryan acquired 26,110 shares via stock option exercise, and on February 28, 2024, he acquired 32,839 shares as performance shares. There is no reportable history of securities sold in the past three months prior to this notice.
AbbVie Inc. officer Stewart Jeffrey Ryan is set to sell 58,949 common shares of the company on March 18, 2024, with an aggregate market value of approximately $10,539,878. The shares to be sold were acquired through stock option exercises and performance shares, both as compensation from the issuer. On March 18, 2024, Ryan acquired 26,110 shares via stock option exercise, and on February 28, 2024, he acquired 32,839 shares as performance shares. There is no reportable history of securities sold in the past three months prior to this notice.
艾伯维公司高管斯图尔特·杰弗里·瑞安定于2024年3月18日出售该公司的58,949股普通股,总市值约为10,539,878美元。待出售的股票是通过股票期权行使和绩效股票收购的,两者都是发行人的补偿。2024年3月18日,瑞安通过行使股票期权收购了26,110股股票,2024年2月28日,他收购了32,839股股票作为绩效股。在本通知之前的过去三个月中,没有可申报的证券销售记录。
艾伯维公司高管斯图尔特·杰弗里·瑞安定于2024年3月18日出售该公司的58,949股普通股,总市值约为10,539,878美元。待出售的股票是通过股票期权行使和绩效股票收购的,两者都是发行人的补偿。2024年3月18日,瑞安通过行使股票期权收购了26,110股股票,2024年2月28日,他收购了32,839股股票作为绩效股。在本通知之前的过去三个月中,没有可申报的证券销售记录。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息